MedTrace Logo

Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

NCT03577587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2022-05-03

No results posted yet for this study

Summary

After preterm birth mothers often suffer from hypogalactia. Herbal galactogogues can be used in order to increase milk production. In this double-blind, randomized, placebo-controlled clinical trial the effect of Silitidil, an extract from milk thistle, on the postpartal milk production in mothers of very premature newborns is investigated.

Conditions

  • Breast Milk Production
  • Human Milk Feeding
  • Hypogalactia
  • Preterm Infant Nutrition

Interventions

DIETARY_SUPPLEMENT

Silitidil for 21 days

daily ingestion of herbal galactagogue Silitidil over time period of 3 weeks

DIETARY_SUPPLEMENT

Placebo for 21 days

daily ingestion of Placebo preparation over time period of 3 weeks

Sponsors & Collaborators

  • DMK Group

    collaborator UNKNOWN

  • Waldkrankenhaus Protestant Hospital, Spandau

    lead OTHER

Principal Investigators

  • Frank Jochum, MD · Head of Paediatric Department

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-14
Primary Completion
2022-02-10
Completion
2022-02-10

Countries

  • Germany

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577587 on ClinicalTrials.gov